MindMed

About:

MindMed provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

Twitter/X: mindmedco

Top Investors: CIBC, Marshall Wace, Canaccord Genuity Group, Deep Track Capital, Janus Henderson Investors

Description:

MindMed provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.

Total Funding Amount:

$449M

Headquarters Location:

New York, New York, United States

Founded Date:

2019-05-30

Contact Email:

info(AT)mindmed.co

Founders:

Robert Barrow

Number of Employees:

101-250